Nationwide Fund Advisors’s Alimera Sciences ALIM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
Sell
-1,346
Closed -$35K 3307
2016
Q1
$35K Hold
1,346
﹤0.01% 3039
2015
Q4
$49K Hold
1,346
﹤0.01% 2996
2015
Q3
$45K Hold
1,346
﹤0.01% 3037
2015
Q2
$93K Buy
1,346
+107
+9% +$7.38K ﹤0.01% 3031
2015
Q1
$93K Sell
1,239
-64
-5% -$5.04K ﹤0.01% 2981
2014
Q4
$108K Sell
1,303
-29
-2% -$2.35K ﹤0.01% 2892
2014
Q3
$108K Hold
1,332
﹤0.01% 2959
2014
Q2
$119K Buy
+1,332
New +$118K ﹤0.01% 2976
2014
Q1
Sell
-903
Closed -$64K 3212
2013
Q4
$64K Hold
903
﹤0.01% 3038
2013
Q3
$51K Buy
903
+543
+151% +$34.1K ﹤0.01% 3047
2013
Q2
$26K Buy
+360
New +$20.8K ﹤0.01% 3063

Other funds holding ALIM

Nationwide Fund Advisors's ALIM Position: Q2 2016 in Review

Nationwide Fund Advisors sold out of Alimera Sciences (ALIM) in Q2 2016, closing a stake of 1,346 shares — an estimated $35K sold.

Nationwide Fund Advisors first reported a position in ALIM in Q2 2013 and held it in 11 quarters. The position peaked at $119K in Q2 2014. 49 funds tracked by Wall St. Rank hold ALIM as of Q2 2016.

  • Nationwide Fund Advisors reported no remaining Alimera Sciences position as of Q2 2016 after selling out during the quarter.
  • Nationwide Fund Advisors sold 1,346 Alimera Sciences shares in Q2 2016, an estimated $35K.
  • Nationwide Fund Advisors first reported a position in Alimera Sciences in Q2 2013 and held it in 11 quarters.
  • Nationwide Fund Advisors's Alimera Sciences position peaked at $119K in Q2 2014.
  • 49 funds tracked by Wall St. Rank held Alimera Sciences as of Q2 2016.

Based on Nationwide Fund Advisors's 13F filing for Q2 2016, filed 9 Aug 2016.